Meeting NewsVideo

VIDEO: IMCgp100 a promising option for uveal melanoma treatment, speaker says

HONOLULU — Early studies have shown IMCgp100 (Immunocore), a bispecific T-cell redirector, to be “extremely promising” for the treatment of uveal melanoma, Richard Carvajal, MD, said at the Association for Research in Vision and Ophthalmology meeting here.

HONOLULU — Early studies have shown IMCgp100 (Immunocore), a bispecific T-cell redirector, to be “extremely promising” for the treatment of uveal melanoma, Richard Carvajal, MD, said at the Association for Research in Vision and Ophthalmology meeting here.

    See more from Association for Research in Vision and Ophthalmology